| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/19/2009 | US20090076168 Amine-based and imine-based polymers, uses and preparation thereof |
| 03/19/2009 | US20090076123 Medical Compositions for Intravesical Treatment of Bladder Cancer |
| 03/19/2009 | US20090076016 Formulations comprising jorumycin-, renieramycin-, safracin- or saframycin-related compounds for treating proliferative diseases |
| 03/19/2009 | US20090075984 Materials and methods relating to protein aggregation in neurodegenerative disease |
| 03/19/2009 | US20090075911 Ester Derivatives of Hyaluronic Acid for the Preparation of Hydrogel Materials by Photocuring |
| 03/19/2009 | US20090075901 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 03/19/2009 | US20090075895 Stabilised Solid Composition of Modified Factor VII |
| 03/19/2009 | US20090075860 Transdermal absorption enhancer |
| 03/19/2009 | US20090075302 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075279 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090075278 Compositions and methods for the diagnosis and treatment of tumor |
| 03/19/2009 | US20090074875 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 03/19/2009 | US20090074870 Alteration of cell membrane for new functions |
| 03/19/2009 | US20090074859 Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
| 03/19/2009 | US20090074858 Sustained-release formulation |
| 03/19/2009 | US20090074855 Enteric coastings for orally ingestible compositions |
| 03/19/2009 | US20090074847 Transport System In Biological Systems |
| 03/19/2009 | US20090074830 Anti-angiogenic compositions and methods of use |
| 03/19/2009 | US20090074828 Poly(amino acid) targeting moieties |
| 03/19/2009 | US20090074819 Polymeric nano-shells |
| 03/19/2009 | US20090074798 System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 03/19/2009 | US20090074707 Shaped body and method for production of said body |
| 03/19/2009 | US20090074706 A four arm-polyethylene glycol-7-ethyl-10-hydroxycamptothecin conjugate, prodrugs of (4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione; anticarcinogenic agents |
| 03/19/2009 | US20090074704 Multi-Arm Polymer Prodrugs |
| 03/19/2009 | US20090074686 Novel inverse latices of copolymers of amps and of n,n-dimethylacrylamide; cosmetic use |
| 03/19/2009 | US20090074685 Polyamide and emollient compositions, products made therefrom, and methods of making and using such compositions and products |
| 03/19/2009 | US20090074681 Stabilized body care products, household products, textiles and fabrics |
| 03/19/2009 | US20090074665 Diagnosis and treatment of cancer:I |
| 03/19/2009 | CA2699794A1 Mitochondria-targeted anti-tumour agents |
| 03/19/2009 | CA2699630A1 Transdermal, alcohol-free, pharmaceutical compositions |
| 03/19/2009 | CA2699488A1 Conjugates of ribosome inactivating toxins with agents that bind to er+ cell receptors |
| 03/19/2009 | CA2699468A1 Composition for preventing virus infection comprising poly-gamma-glutamic acid |
| 03/19/2009 | CA2698944A1 Tartrate salts or complexes of quinazoline based egfr inhibitors containing a zinc binding moiety |
| 03/19/2009 | CA2698882A1 Pharmaceutical compositions for oral use for treating patients affected by obesity |
| 03/19/2009 | CA2698812A1 Drug carriers |
| 03/19/2009 | CA2697756A1 Liquid crystal emulsion-type pharmaceutical composition containing cyclosporine, and method of treating cutaneous disease therewith |
| 03/18/2009 | EP2036980A1 Down regulation of gene expression using virus-like particles charged with nucleic acid |
| 03/18/2009 | EP2036575A1 Pharmaceutical compositions for oral use for treating patients affected by obesity |
| 03/18/2009 | EP2036565A1 Preparation for external application to skin containing triterpenic acid |
| 03/18/2009 | EP2036558A2 Orally administrable opioid formulations having extended duration of effect |
| 03/18/2009 | EP2036549A1 Novel Composition |
| 03/18/2009 | EP2036544A1 Dosage form of powder agglomerates |
| 03/18/2009 | EP2036541A1 Methods and compositions for pulmonary delivery of insulin |
| 03/18/2009 | EP2036540A2 Improved injectable dispersions of propofol |
| 03/18/2009 | EP2036539A1 Stable formulations of amylin and its analogues |
| 03/18/2009 | EP2035566A2 Materials and complexes for the delivery of biologically-active material to cells |
| 03/18/2009 | EP2035488A1 Micelles for drug delivery |
| 03/18/2009 | EP2035469A1 Two step miniemulsion process |
| 03/18/2009 | EP2035441A1 Cyanocobalamin low viscosity aqueous formulations for intranasal delivery |
| 03/18/2009 | EP2035061A1 An adsorption device |
| 03/18/2009 | EP2035043A2 Rna nanoparticles and nanotubes |
| 03/18/2009 | EP2035041A2 Conjugates for innate immunotherapy of cancer |
| 03/18/2009 | EP2035040A2 Pharmaceutical composition for administration by injection |
| 03/18/2009 | EP2035018A1 Pathogenic attenuation via the administration of an equilibiotic compound |
| 03/18/2009 | EP2035017A2 Polymers with antimicrobial activity containing quaternary ammonium groups |
| 03/18/2009 | EP2035008A2 Compositions and methods for preventing or reducing postoperative ileus and gastric stasis in mammals |
| 03/18/2009 | EP2034984A2 Method of treating atrophic vaginitis |
| 03/18/2009 | EP2034976A2 Delivery device having self-assembling dendritic polymers and method of use thereof |
| 03/18/2009 | EP2034966A1 A stabilised composition comprising ace inhibitors |
| 03/18/2009 | EP2034963A2 Gel-formulations of hydrophobic photosensitizers for mucosal applications |
| 03/18/2009 | EP2034961A1 Solubilisate formulations |
| 03/18/2009 | EP2034954A2 Non-viral compositions and methods for transfecting gut cells in vivo |
| 03/18/2009 | EP2034951A2 Rehydratable pharmaceutical product |
| 03/18/2009 | EP2034853A1 Formulations comprising a vitamin and the use thereof to make fortified feed and personal care formulations |
| 03/18/2009 | EP1948131B1 Pharmaceutical composition free from dexpanthenol, calcium ions, and phosphate, and use of calcium chelating agent and ophthalmologically compatible viscosity regulator |
| 03/18/2009 | EP1713466B1 Antiparasitic composition containing an organic amine salt of closantel |
| 03/18/2009 | EP1620129B1 Cyanovirin variant-polymer conjugates |
| 03/18/2009 | EP1462112B1 Remedies for dry eye and diseases associated with dry eye |
| 03/18/2009 | EP1399499B1 Agent for the prevention and treatment of sexually transmitted diseases-i |
| 03/18/2009 | EP1399482B1 Determination of bone-sialoprotein in bodily fluids for oncological problems |
| 03/18/2009 | EP1389096B1 Delivery of opioids through an inhalation route |
| 03/18/2009 | EP1377273B1 Method for producing an isoflavone concentrate |
| 03/18/2009 | EP1353624B1 Pharmaceutical compositions of a non-enteric coated proton pump inhibitor with a carbonate salt and bicarbonate salt combination |
| 03/18/2009 | EP1333816B1 Medicine based on anti-hyperglycaemic microcapsules with prolonged release and method for preparing same |
| 03/18/2009 | EP1292316B1 Hemostatic compositions of polyacids and polyalkylene oxides and methods for their use |
| 03/18/2009 | EP1231877A4 Transdermal administration of huperzine |
| 03/18/2009 | EP1218498B1 Encapsulation of sensitive components into a matrix to obtain discrete shelf-stable particles |
| 03/18/2009 | EP1185288A4 Hemoactive compositions and methods for their manufacture and use |
| 03/18/2009 | EP1077678A4 Mucoadhesive compositions for administration of biologically active agents to animal tissue |
| 03/18/2009 | EP1037642B1 Modified polysaccharides exhibiting altered biological recognition |
| 03/18/2009 | EP0814834B2 Non-toxic immunogens derived from a retroviral regulatory protein, antibodies directed against said immunogens, preparation method therefor, and pharmaceutical compositions containing the same |
| 03/18/2009 | CN101389356A Drug delivery material |
| 03/18/2009 | CN101389355A Bifunctional resorcinol, thioresorcinol, and dithioresorcinol derivative metal chelating conjugates |
| 03/18/2009 | CN101389354A Four branched dendrimer-PEG for conjugation to proteins and peptides |
| 03/18/2009 | CN101389353A Enteric gelatinous nutrient and method of preparing the same |
| 03/18/2009 | CN101389343A Doxorubicin formulations for anti-cancer use |
| 03/18/2009 | CN101389333A Stabilized pharmaceutical composition |
| 03/18/2009 | CN101389323A Pharmaceutical composition comprising oseltamivir phosphate |
| 03/18/2009 | CN101389317A Controlled release solid preparation |
| 03/18/2009 | CN101389316A Controlled release solid preparation |
| 03/18/2009 | CN101386677A Polyaminoacids functionalized by alpha tocopherol and uses thereof, particular for therapeutic applications |
| 03/18/2009 | CN101386671A Method for preparing environmental responsibility mesoporous silicon sphere |
| 03/18/2009 | CN101386625A Vinflunine derivates and preparation method thereof and application thereof in preparing medicament for targeted therapy solid tumors, liver cancer or lung cancer |
| 03/18/2009 | CN101385860A Camptothecine and non-linear polyethyleneglycol prodrug of derivative thereof |
| 03/18/2009 | CN101385859A Glutathione based delivery system |
| 03/18/2009 | CN101385858A Purified PEG human growth hormone conjugates and preparation thereof |
| 03/18/2009 | CN101385857A Novel nano preparation with stable protein and preparation method and use thereof |
| 03/18/2009 | CN101385856A Controllable slow-releasing nano hydroxyapatite with efficient absorption for antalzyme and preparation method thereof |
| 03/18/2009 | CN101385843A Nano medicine magnet therapy plaster for relieving the swelling and easing pain |
| 03/18/2009 | CN101385821A Asthma control coating agent and preparation technique thereof |